FUL FY2025 SEC EDGAR DEF 14A #28 of 168 in industry

Fuller H B Co CEO pay ratio

The CEO earned $8.8M in FY2025 against median worker pay of $64,315 · Chemicals & Pharmaceuticals.

State
MN
Filing date
2026-03-04
Industry
Chemicals & Pharmaceuticals
Industry rank
#28/168

Data updated August 2026

Subscribe to Fuller H B Co CEO pay filing updates (RSS)

CEO-to-worker pay ratio
137:1
Moderate (Scale: 0–1000:1)
CEO pay
$8.8M
Median worker
$64,315

Answer first

Fuller H B Co's FY2025 CEO total of $8.8M ranks #607 of 1,423 complete filings; its 137:1 pay ratio ranks #474. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $64,315. Industry placement uses the FY2025 SIC-28 peer cohort (# 28 of 168, 84th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#607
$8.8M of 1,423 FY2025
Ratio rank
#474
137:1 of 1,423
Industry pct
84th
top quartile of industry peers by pay ratio

How Fuller H B Co ranks nationally

Fuller H B Co CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$8,830,569 Top 43% higher than 57% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Fuller H B Co vs. Chemicals & Pharmaceuticals peers

CEO total pay ($8.8M) against pay ratio (137:1) for Fuller H B Co (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both05747903.811495807.517243711.322991615.137.0:164.3:191.5:1118.7:1145.9:1CEO total payPay ratio (CEO : median worker)Fuller H B Co, CEO total pay: 8830569 · Pay ratio (CEO : median worker): 137:1Fuller H B CoAmphastar Pharmaceuticals, Inc., CEO total pay: 8309350 · Pay ratio (CEO : median worker): 135:1Amphastar Pharmaceuticals, Inc.Balchem Corp, CEO total pay: 7894874 · Pay ratio (CEO : median worker): 135:1Balchem CorpLyondellBasell Industries N.V., CEO total pay: 110140 · Pay ratio (CEO : median worker): 141:1LyondellBasell Industries N.V.Bristol Myers Squibb Co, CEO total pay: 21902021 · Pay ratio (CEO : median worker): 131:1Bristol Myers Squibb CoAxalta Coating Systems Ltd., CEO total pay: 9551721 · Pay ratio (CEO : median worker): 130:1Axalta Coating Systems Ltd.
Fuller H B Co vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Fuller H B Co's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Fuller H B Co

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
137:1
FY2025
vs prior FY
+16:1
from FY2024 121:1
CEO $ YoY
+13%
$8.8M latest
Filings shown
5
FY2021–2025
Fuller H B Co CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $11.6M - $72,205 161:1 -
2022 $9.6M -17% $63,331 152:1 -9:1
2023 $5.1M -48% $60,417 84:1 -68:1
2024 $7.8M +55% $64,828 121:1 +37:1
2025 $8.8M +13% $64,315 137:1 +16:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 39368, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
137:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$8.8M
Companies in Industry
168
vs. Industry Median
Above
#28 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Fuller H B Co: MID · HEAVY pay ratio

Fuller H B Co's FY2025 ratio 137:1 ranks #28 of 168 Chemicals & Pharmaceuticals filers (84th percentile). the CEO earned 137× the median employee ($64,315) in FY2025.

Median employee $64,315 (PAR-MED); MID · HEAVY stamps put about 137 median-wage years per CEO year.

CEO Total Pay

$8.8M

FY2025 Summary Compensation, above median

Pay Ratio

137:1

Near industry median

Fuller H B Co in the higher Chemicals & Pharmaceuticals third

Fuller H B Co's FY2025 ratio 137:1 ranks #28 of 168 Chemicals & Pharmaceuticals filers (84th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Fuller H B Co's $8.8M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #607 and ratio rank #474 split - treat 137:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$8.8M
Median Employee Pay
$64,315
Pay Ratio
137:1
Filing Date
2026-03-04

Company Info

Ticker
FUL
CIK
39368
Industry
Chemicals & Pharmaceuticals
SIC Code
2891
State
MN
SEC EDGAR DEF 14A for CIK 39368, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read with Fuller H B Co

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · PAR-MED.

Data sourced from SEC EDGAR DEF 14A for Fuller H B Co (CIK 39368), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.